Kato, T., Ono, H., Fujii, M., Akahoshi, K., Ogura, T., Ogawa, K., . . . Tanabe, M. (2021). Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells. Public Library of Science (PLoS).
Style de citation Chicago (17e éd.)Kato, Tomotaka, et al. Cytoplasmic RRM1 Activation as an Acute Response to Gemcitabine Treatment Is Involved in Drug Resistance of Pancreatic Cancer Cells. Public Library of Science (PLoS), 2021.
Style de citation MLA (8e éd.)Kato, Tomotaka, et al. Cytoplasmic RRM1 Activation as an Acute Response to Gemcitabine Treatment Is Involved in Drug Resistance of Pancreatic Cancer Cells. Public Library of Science (PLoS), 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.